Click Here!

  eMJA     The Medical Journal of Australia

Home | Issues | eMJA shop | Classifieds | Contact | More... | Topics | Search | Login | Buy full access   

Editorial

Illness or disease? The case of chronic fatigue syndrome

Not every illness can be defined as a disease before care and treatment should commence

MJA 2000; 172: 471-472

Few disorders in modern medical practice generate such uncertainty and controversy as the enigmatic clinical condition known as chronic fatigue syndrome (CFS). Much of the difficulty surrounds the dominant reductionist paradigm of medical practice, which emphasises diagnostic tests, recognised pathophysiology, and established pharmacological and other physical treatments. Broader paradigms, incorporating other cultural and psychosocial perspectives, are crucial for clinicians who treat patients with this challenging disorder.

Prolonged fatigue is reported by about 25% of all patients presenting to Australian general practice.1 Such fatigue states represent a continuum of severity ranging from the mild and transient symptoms generally attributable to intercurrent infection or minor mental disorder through to the more rare, severe and prolonged fatigue disorders. In about 1% of patients attending general practice, the fatigue state will meet diagnostic criteria for CFS (Box).

Although most people present to their doctors with characteristic symptom patterns, current clinical practice relies heavily on diagnostic tests for accurate recognition of almost all disease states. Consequently, doctors frequently explain the patient's suffering in pathophysiological terms based on test results, and treatments are often provided to "fix the numbers" rather than the problem identified by the patient. While doctors readily provide specific treatments that have a firm evidence base, many have little interest in the kind of medicine that maximises non-specific therapeutic benefits, such as providing complex or aversive treatments and encouraging adherence to non-pharmacological interventions.

This makes it difficult for patients with poorly defined disorders, or disorders without simple treatment options, to find suitable care. In addition, the increasing specialisation of medicine creates problems for those patients whose disorders do not fit within distinct subspecialty boundaries. Each of these issues contributes to the current dilemmas in managing people with CFS.

Syndromal diagnoses were once common in clinical medicine and still persist in situations where disease processes are complex or obscure, such as systemic lupus erythematosus. Syndromal diagnoses are common in neurology (eg, migraine and other headache syndromes), and in psychiatry (eg, major depression), where there is a strong reliance on patient self-report rather than clinical signs or laboratory markers. Many clinical specialties identify syndromes closely related to CFS, but with varied emphasis on a particular symptom feature, such as musculoskeletal pain in fibromyalgia and gastrointestinal disturbance in irritable bowel syndrome.

Clinically, CFS has the characteristics of a neuropsychiatric disorder. Its major symptoms (disturbed perception of fatigue and pain, sleep disturbance, neurocognitive difficulties and mood disturbances) suggest a non-localised disturbance of central nervous system function. However, its pathophysiological basis remains obscure. A diverse array of aetiologies has been proposed (including immunological, infective, metabolic, neuroendocrine and psychiatric hypotheses), but no simple explanatory model has been supported by well-controlled studies. Indeed, the heterogeneity within patient groups labelled as having CFS makes it likely that more than one process is operative.3

Thus, CFS challenges the standard concept of discrete disease categories linked to specific aetiologies. The practitioner is confronted with the challenge of explaining the patient's symptoms without reference to a coherent biomedical model. In these circumstances, doctors often fall back on outdated notions of "psychosomatic disease", which patients generally interpret as "imaginary illness". In the face of medical disinterest or scepticism, patients are frequently driven to seek simplistic "alternative" explanations to legitimise their illness experience, and may be tempted to pursue useless or harmful unproven therapies.

How can patients and practitioners engage in a more productive dialogue? To begin with, doctors should be prepared to acknowledge the limitations of our current state of knowledge. In the absence of a clear understanding of the underlying pathophysiology, CFS is best described as an illness rather than a disease.4 Illness is a subjective state of suffering -- physical, psychological and social -- and can only be understood and defined with reference to the sick individual.5 Disability arises when illness interferes with the individual's ability to function normally. People with CFS are clearly ill, and are often disabled, even though an underlying disease process has not yet been identified. Our goal as medical practitioners is not only to identify and treat disease, but also to help relieve suffering and disability, whatever the cause.

Unfortunately, medical conditions for which there are limited therapeutic approaches are rarely popular territories for practitioners. Various antiviral, immunoregulatory, metabolic, and antidepressive drug treatments for CFS have been subjected to randomised controlled trials, but none has demonstrated definite efficacy. In disorders associated with broad disturbances of central nervous system function there is commonly an interplay between cultural, personal and biomedical factors. Thus, it is not surprising that cognitive-behavioural approaches have shown benefit in clinical trials,6 but it is not yet clear how generally applicable these findings are.

A recent evaluation of patients with chronic fatigue in Hong Kong may provide an important insight for our "Western" medical practice.7 For these patients the notion of having a "medical" versus "psychiatric", or "biomedical" versus "psychosocial", cause of their illness made little sense. Their perception was that, while they were clearly unwell, the potential causes of that suffering could lie across a broad domain of personal, social or medical factors. If Australian patients and their doctors could rediscover this basic concept, and could also accept prolonged fatigue as a legitimate illness experience, there would be no need for the polarisation of aetiological models (and political views) that has become characteristic of medical practice in relation to CFS in the USA and UK. This unnecessary polarisation is intellectually shallow and harmful to patients.

To build an effective therapeutic alliance, doctors should endeavour to maximise non-specific treatment effects by adopting an empathic and non-judgemental style, by displaying acceptance of their patient's suffering, and by demonstrating a commitment to continued care. Rejecting the patient's illness experience is likely to promote feelings of alienation and to perpetuate ill-health. The cornerstones of good management include providing information about the illness and its natural history; empirical treatment of disturbances of mood and sleep which commonly co-occur in CFS; and encouraging a rehabilitative approach to the illness, including graded physical activity as well as psychological and social support.

Andrew R Lloyd
Associate Professor, Inflammation Research Unit
School of Pathology, University of New South Wales

Ian B Hickie
Professor, School of Psychiatry, University of New South Wales

Robert H Loblay
Associate Professor, Department of Clinical Immunology
Royal Prince Alfred Hospital, Sydney

  1. Hickie I, Hooker AW, Hadzi-Pavlovic D, et al. Fatigue in selected primary care settings: sociodemographic and psychiatric correlates. Med J Aust 1996; 164: 585-588.
  2. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953-959.
  3. Hickie I, Lloyd A, Hadzi-Pavlovic D, et al. Can the chronic fatigue syndrome be defined by distinct clinical features? Psychol Med 1995; 25: 925-935.
  4. Jennings D. The confusion between disease and illness in clinical medicine. Can Med Assoc J 1986; 135: 865-870.
  5. Cassell EJ. The nature of suffering and the goals of medicine. New York: Oxford University Press, 1991.
  6. Wessely S, Hotopf M, Sharpe M. Chronic fatigue and its syndromes. New York: Oxford University Press, 1998.
  7. Lee S, Yu H, Wing YK, et al. Psychiatric morbidity and illness experience of primary care patients with chronic fatigue in Hong Kong. Am J Psychiatry 2000; 157: 380-384.

©MJA 2000
Make a comment

Other articles have cited this article:

Home | Issues | eMJA shop | Terms of use | Classifieds | More... | Contact | Topics | Search

The Medical Journal of Australia    eMJA  


Readers may print a single copy for personal use. No further reproduction or distribution of the articles should proceed without the permission of the publisher. For permission, contact the Australasian Medical Publishing Company.
Journalists are welcome to write news stories based on what they read here, but should acknowledge their source as "an article published on the Internet by The Medical Journal of Australia <http://www.mja.com.au>".

<URL: http://www.mja.com.au/> © 2000 Medical Journal of Australia.
We appreciate your comments.


Diagnostic criteria for chronic fatigue syndrome2

A.Clinically evaluated, unexplained, persistent or relapsing fatigue persistent for six months or more that is of new or definite onset; is not the result of ongoing exertion; is not substantially alleviated by rest; and results in substantial reduction in previous levels of occupational, educational, social or personal activities;
and

B.Four or more of the following symptoms are concurrent, persistent for six months or more, and must not have predated the fatigue:

  • Impaired short term memory or concentration
  • Sore throat
  • Tender cervical or axillary lymph nodes
  • Muscle pain
  • Multijoint pain without arthritis
  • Headaches of a new type, pattern, or severity
  • Unrefreshing sleep
  • Postexertional malaise lasting more than 24 hours.
  • Back to text